(ii) Reproductive Endpoints: Given the limited information content, weak priors or conservative assumptions are warranted
Curr Cancer Drug Targets 18:266277 Fierro-Fernndez M, Miguel V, Mrquez-Expsito L, Nuevo-Tapioles C, Herrero JI, Blanco-Ruiz E, Tituaa J, Castillo C, Cannata P, Monsalve M, Ruiz-Ortega M, Ramos R, Lamas S (2020) MiR-9-5p protects from kidney fibrosis by metabolic reprogramming
We do not reject a review because it is negative
By staying informed, maintaining rigorous standards, and prioritizing safety, health professionals can effectively support clients navigating this exciting frontier of metabolic medicine
There is also a risk that, because it promotes blood vessel generation, it might also speed the growth of tumors, if the user happens to already have one